GRAND RAPIDS - A team of international scientists has made a significant breakthrough in understanding the cause of bile duct cancer, a deadly type of liver cancer. By identifying several new genes frequently mutated in bile duct cancers, researchers are paving the way for better understanding of how bile duct cancers develop. Their discovery is
GRAND RAPIDS - Phillip A. Sharp, Ph.D., winner of the 1993 Nobel Prize in Physiology or Medicine for his discovery of RNA splicing, will be honored May 23 at Van Andel Institute as the first recipient of the Han Mo Koo Memorial Award. The award is named after one of VAI?s founding scientists who succumbed
ANN ARBOR - Rubicon Genomics has launched the first product in its ThruPLEX family of sample preparation kits designed and optimized for next generation sequencing. ThruPLEX-FD kits leverage Rubicon?s patented DNA repair and ligation methods to deliver significantly faster and more sensitive sequencing of plasma, formalin-fixed, ChIP and other fragmented DNA with substantially increased throughput.
GRAND RAPIDS - Van Andel Research Institute and Dako, the Danish-based, worldwide supplier of cancer diagnostic tools, Wednesday announce an agreement to license, manufacture and distribute cancer diagnostics utilizing the MET4 Antibody. The MET4 Antibody, developed by George F. Vande Woude, Ph.D. and Brian Cao, M.D. of VARI and Beatrice Knudsen, M.D., Ph.D., formerly of
ANN ARBOR - Michael Stebbins, assistant director for biotechnology in the White House Office of Science and Technology Policy, provided members of MichBio a glimpse of a new bioeconomy program scheduled to be unveiled in Washington next week. Speaking at the trade group?s annual meeting, Stebbins reportedly said the administration is working to do whatever
GRAND RAPIDS ? Researchers in Sweden have discovered a new stem cell in the adult brain that can proliferate and form new brain cells. Van Andel Research Institute scientists hope to take advantage of the finding to develop methods to heal and repair disease and injury in the brain. Analyzing brain tissue from biopsies, the
ANN ARBOR ? A team from the University of Michigan, has helped deliver stem cells into the spines of patients with Lou Gehirg's disease, opening the door to a new treatment. In a paper published online ahead of print publication in the peer-reviewed journal Stem Cells, a team from the U-M, Emory University and study
PLYMOUTH - Esperion Therapeutics announced the appointment of Noah Rosenberg, MD, as its chief medical officer. Dr. Rosenberg will lead the Esperion clinical advisory board and will develop and manage the company's clinical programs. He will also manage the regulatory review process for the company's innovative investigational therapies to prevent, treat and reverse cardiovascular and
ANN ARBOR - Dean Baker, the former GM Body-in-White Chief Manufacturing Engineer, is a new principal at Fulcrum Edge. Baker holds a Bachelor of Science degree in Electrical Engineering from General Motors Institute (Kettering University), a Masters degree in Electrical Engineering from the University of Michigan, and is certified as a Project Management Professional by
PLYMOUTH - Esperion Therapeutics announced positive results from a Phase 2 clinical trial for ETC-1002, an LDL cholesterol lowering drug. This small molecule activator of AMP Kinase has demonstrated preclinical and clinical activity as a metabolic regulator of imbalances in lipid and carbohydrate metabolism. Results were presented Tuesday in an oral presentation at the 2012